Zafirlukast
Back to searchMolecule Structure
Scientific Name
Zafirlukast
Description of the Drug
Zafirlukast is a leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00549
http://www.drugbank.ca/drugs/DB00549
Brand Name(s)
Accolate, Zafirlukast
Company Owner(s)
Strides Pharma Global Pte Ltd, Rising Pharmaceuticals Inc, Annora Pharma Private Ltd, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cysteinyl leukotriene receptor 1 | SINGLE PROTEIN | ANTAGONIST | CHEMBL1798 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4175 | |
| PharmGKB | PA451949 | |
| Human Metabolome Database | HMDB0014689 | |
| DrugBank | DB00549 | |
| PubChem: Thomson Pharma | 14788829 | |
| PubChem | 5717 | |
| Mcule | MCULE-2053856450 | |
| LINCS | LSM-5792 | |
| Nikkaji | J322.324H | |
| PDBe | ZLK | |
| BindingDB | 50009073 | |
| EPA CompTox Dashboard | DTXSID5023746 | |
| DrugCentral | 2855 | |
| ChemicalBook | CB8703479 | |
| Guide to Pharmacology | 3322 | |
| rxnorm | ZAFIRLUKAST | ACCOLATE |
| PubChem: Drugs of the Future | 12014035 | |
| KEGG Ligand | C07206 | |
| ChEBI | 10100 | |
| ZINC | ZINC000000896717 |
